Hereditary Coproporphyria (HCP): Symptoms, Causes
Hereditary coproporphyria (HCP) is a rare genetic disorder characterized by a deficiency in the enzyme coproporphyrinogen oxidase (CPOX), which is crucial in the heme biosynthesis…
Hereditary Angioedema (HAE): Causes, Symptoms
Hereditary Angioedema (HAE) is a rare genetic disorder that causes recurrent episodes of severe swelling in various parts of the body. This condition can significantly…
HER2-Positive Gastric Adenocarcinoma
HER2-positive gastric adenocarcinoma is a subtype of stomach cancer characterized by the overexpression of the HER2 (human epidermal growth factor receptor 2) protein. This aggressive…
HER2-Positive Colorectal Cancer: A Comprehensive Guide
HER2 positive colorectal cancer is a rare but aggressive subtype of colorectal cancer characterized by an overexpression of the HER2 gene. This condition affects a…
HER2 Positive Carcinoma of Breast: Causes, Diagnosis
HER2 positive carcinoma of the breast is an aggressive subtype of breast cancer characterized by the overexpression of the human epidermal growth factor receptor 2…
HER2 Positive Biliary Tract Malignancy
HER2 positive biliary tract malignancy is a rare but aggressive form of cancer that affects the bile ducts, gallbladder, and ampulla of Vater. Understanding its…
HER2-Positive Adenocarcinoma of Gastroesophageal Junction
HER2-positive adenocarcinoma of the gastroesophageal junction (GEJ) is a rare yet aggressive malignancy that requires targeted treatment strategies. This condition is characterized by the overexpression…
HER2 Negative Gastric or Gastroesophageal Junction
HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma is a challenging form of cancer with distinct characteristics that require specialized treatment approaches. Understanding its pathology, diagnosis,…
HER2-Negative and CLDN18.2-Positive Gastric
Gastric and gastroesophageal junction (GEJ) adenocarcinomas are aggressive malignancies with limited treatment options. Recent advancements have identified CLDN18.2 as a promising biomarker in patients with…
HER2 Mutant Non-Small Cell Lung Cancer
Human Epidermal Growth Factor Receptor 2 (HER2) mutant non-small cell lung cancer (NSCLC) is a rare but significant subtype of lung cancer characterized by specific…